Among the survey's other findings:
- The majority of female ob/gyns believe menstrual suppression is safe when used long-term (69%) or occasionally (30%). More than half (53%) say they've used oral contraceptives to suppress their own menstruation.
- Among those female ob/gyns who said they had undergone a caesarean delivery, 78% said it was performed for medical reasonsnot as an elective. When asked if they would perform an elective C/S if a patient requested one, 36% said they would not, 32% said they would, and another 28% said it would depend on the circumstances.
- Female ob/gyns are more likely than American women in general to be screened for cervical or breast cancer. While 89% of American women of reproductive age have had a Pap test within the past 3 years, 78% of female ob-gyns had the test within the past 18 months and 90% had one within the past 2 years. Additionally, 70% of American women over age 40 in 2002 had a mammogram in the previous 2 years, while 73% of female ob/gyns age 48 and over had one in the past year and 86% had one within the past 2 years.
- 50% of female ob/gyns use hormone therapy to treat their own menopausal symptoms, and 19% said they did not use any treatment. Other types of treatment used by female ob/gyns include antidepressants (13%) to treat hot flashes and alternative natural therapies (13%), such as botanical black cohosh.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
